💊FDA PHARMA today 💊FDA PHARMA to Saturday December 16th, 2017By Tokio X'press EMA, Pharmaceutical kyowa-kirin, Takeda 💊FDA PHARMA to
💊Kyowa Hakko Kirin, anti-Ccr4 humanized antibody acceptance application for European approval of Mogum Lysumab 20171027 💊Kyowa Hakko K Friday October 27th, 2017By Tokio X'press EMA, Pharmaceutical kyowa-kirin 💊Kyowa Hakko K
